These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 15667209

  • 21. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F.
    Toxicology; 2009 May 17; 259(3):133-9. PubMed ID: 19428953
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica.
    Koellner G, Kryger G, Millard CB, Silman I, Sussman JL, Steiner T.
    J Mol Biol; 2000 Feb 18; 296(2):713-35. PubMed ID: 10669619
    [Abstract] [Full Text] [Related]

  • 28. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G, Adani R, Yacov G, Yishay S, Teitlboim S, Tveria L, Limanovich O, Kushnir M, Meshulam H.
    Toxicology; 2007 Apr 20; 233(1-3):187-98. PubMed ID: 17129656
    [Abstract] [Full Text] [Related]

  • 29. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
    Gilley C, MacDonald M, Nachon F, Schopfer LM, Zhang J, Cashman JR, Lockridge O.
    Chem Res Toxicol; 2009 Oct 20; 22(10):1680-8. PubMed ID: 19715348
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
    Lockridge O, Blong RM, Masson P, Froment MT, Millard CB, Broomfield CA.
    Biochemistry; 1997 Jan 28; 36(4):786-95. PubMed ID: 9020776
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP.
    Biochemistry; 1997 Dec 02; 36(48):14642-51. PubMed ID: 9398183
    [Abstract] [Full Text] [Related]

  • 37. X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.
    Nachon F, Carletti E, Wandhammer M, Nicolet Y, Schopfer LM, Masson P, Lockridge O.
    Biochem J; 2011 Feb 15; 434(1):73-82. PubMed ID: 21091433
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M, Musilova L, Renault F, Brazzolotto X, Misik J, Novotny L, Froment MT, Gillon E, Loiodice M, Verdier L, Masson P, Rochu D, Jun D, Nachon F.
    Toxicol Lett; 2011 Sep 25; 206(1):14-23. PubMed ID: 21683774
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.